Research ArticleIMMUNOLOGY

Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy

See allHide authors and affiliations

Science Advances  23 Oct 2019:
Vol. 5, no. 10, eaaw6870
DOI: 10.1126/sciadv.aaw6870

Article Information

vol. 5 no. 10

Online ISSN: 
History: 
  • Received for publication January 16, 2019
  • Accepted for publication September 16, 2019
  • .

Author Information

  1. Xiao Han1,*,
  2. Shufang Shen1,*,
  3. Qin Fan1,
  4. Guojun Chen2,
  5. Edikan Archibong3,
  6. Gianpietro Dotti3,
  7. Zhuang Liu1,,
  8. Zhen Gu2,4, and
  9. Chao Wang1,
  1. 1Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu 215123, China.
  2. 2Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  3. 3Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  4. 4California NanoSystems Institute, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  1. Corresponding author. Email: cwang{at}suda.edu.cn (C.W.); guzhen{at}ucla.edu (Z.G.); zliu{at}suda.edu.cn (Z.L.)
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: October 2019 to June 2020

AbstractFullPdf
Oct 20192052394880
Nov 20191391107678
Dec 201962794351
Jan 202085765344
Feb 202057673275
Mar 202066548247
Apr 202028449282
May 202031414274
Jun 202085138

Stay Connected to Science Advances

Navigate This Article